The France infusion therapy devices market is anticipated to grow at a CAGR of 6.9% during the forecast period. France infusion therapy devices market is being primarily driven by the increasing prevalence of chronic diseases and the rising aging population in the country. As per the United Nations, in 2019, there were 13.3 million people aged 65 years or over, which is 20.4% of the total population. Nearly 24.1% of the population is expected to be aged 65 years or over by 2030, which will be nearly 16.1 million people.
Visit for Global Infusion Therapy Devices Market Report at: https://www.omrglobal.com/industry-reports/infusion-therapy-devices-market-size
Owing to this significant rise in the aging population, the providers of infusion pumps are focusing on expanding their geographical presence in France. For instance, in February 2019, Q Core Medical, a manufacturer of smart infusion systems for hospital and ambulatory care settings, declared the opening of a new European office in Marseille, France. With this new office, the company will conduct direct sales operations of Q Core's hospital and homecare infusion systems in France and other European markets.
The France infusion therapy devices market is segmented on the basis of product type, application, and end-user. Based on the product type, the market is classified into infusion pumps and consumables & accessories. Based on the application, the market is segregated into oncology, diabetes, gastroenterology, analgesia, hematology, and others. The end-user segment is classified into hospitals, home care, and ambulatory surgery centers.
The major players contributing to the growth of the France infusion therapy devices market include B. Braun Melsungen AG, Medtronic PLC, Novartis AG, and Terumo Corp. The players operating in the market adopt various strategies such as technology development, product launch, merger and acquisitions for gaining a sustainable position in the market that further propels the growth of the market.
Research Methodology
The market study of the France infusion therapy device market is incorporated by extensive primary and secondary research conducted by a research team at OMR. Secondary research has been conducted to refine the available data to break down the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The OMR team collects facts and data related to the market from different geographies to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macroeconomic factors. The numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analysts to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders, and industry experts to get first-hand information. Primary research brings authenticity to our reports.
Secondary Sources Include
The report is intended for infusion therapy device market players, potential entrants, medical device companies, healthcare providers, investment companies, research institutes, universities, government organizations for overall market analysis and competitive analysis. The report provides an in-depth analysis of the market size and will serve as a source for 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions.
Market Segmentation
1. France Infusion Therapy Devices Market Research and Analysis by Product Type.
2. France Infusion Therapy Devices Market Research and Analysis by End-User.
3. France Infusion Therapy Devices Market Research and Analysis by Application.
The Report Covers
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
2.3. Rules & Regulations
3. Competitive Landscape
3.1. Company Share Analysis
3.2. Key Strategy Analysis
3.3. Key Company Analysis
3.3.1. Overview
3.3.2. Financial Analysis
3.3.3. SWOT Analysis
3.3.4. Recent Developments
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. France Infusion Therapy Devices Market by Product Type
5.1.1. Infusion Pumps
5.1.2. Consumables & Accessories
5.2. France Infusion Therapy Devices Market by Application
5.2.1. Oncology
5.2.2. Diabetes
5.2.3. Gastroenterology
5.2.4. Analgesia
5.2.5. Hematology
5.2.6. Others (Pediatrics)
5.3. France Infusion Therapy Devices Market by End-User
5.3.1. Hospitals
5.3.2. Homecare
5.3.3. Ambulatory Surgery Centers
6. Company Profiles
6.1. B. Braun Melsungen AG
6.2. Baxter International, Inc.
6.3. Becton, Dickinson and Co.
6.4. Caesarea Medical Electronics Ltd.
6.5. Fresenius SE & Co. KGaA
6.6. Johnson & Johnson Services, Inc.
6.7. Medtronic PLC
6.8. Novartis AG
6.9. Smith’s Group PLC
6.10. Terumo Corp.
1. FRANCE INFUSION THERAPY DEVICES MARKET RESEARCH AND ANALYSIS BY PRODUCT, 2018-2025 ($ MILLION)
2. FRANCE INFUSION THERAPY DEVICES MARKET RESEARCH AND ANALYSIS BY END-USER, 2018-2025 ($ MILLION)
3. FRANCE INFUSION THERAPY DEVICES MARKET RESEARCH AND ANALYSIS BY APPLICATION, 2018-2025 ($ MILLION)
1. FRANCE INFUSION THERAPY DEVICES MARKET SHARE BY PRODUCT TYPE, 2018 VS 2025 (%)
2. FRANCE INFUSION THERAPY DEVICES MARKET SHARE BY END-USER, 2018 VS 2025 (%)
3. FRANCE INFUSION THERAPY DEVICES MARKET SHARE BY APPLICATION, 2018 VS 2025 (%)